Emma Sangalang

574 citations
10 papers · 254 indexed · h-index 6
Topics
Immunotherapy and Immune Responses (8 papers)Phagocytosis and Immune Regulation (5 papers)Cancer Immunotherapy and Biomarkers (3 papers)
Journals
SHILAP Revista de lepidopterologíaBloodPLoS ONE
Partner nations
United States

In The Last Decade

Emma Sangalang

8 papers receiving 243 citations

Peers

Emma Sangalang
Comparison fields: 5 of 38
  • Immunology 211
  • Oncology 76
  • Physiology 51
  • Molecular Biology 42
  • Radiology, Nuclear Medicine and Imaging 28
Replace Lucile Broyer with:
Lucile Broyer Switzerland
Haizeng Zhang China
Kristi L. Manjarrez United States
Dieke J. van Rees Netherlands
Jim Middelburg Netherlands
Ludovica Arpinati Israel
Sandrine Susini France
Martina Schuessler‐Lenz Germany
Woo‐Sung Chang South Korea
Nela Klein-González Germany
Emma Sangalang relative to Lucile Broyer Switzerland Lucile Broyer's profile →
Citations per field
00.5×1.5×2.2×
Lucile Broyer · 1×
Citations per year

Countries citing papers authored by Emma Sangalang

Since Specialization
Citations

This map shows the geographic impact of Emma Sangalang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Sangalang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Sangalang more than expected).

Fields of papers citing papers by Emma Sangalang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Sangalang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Sangalang. The network helps show where Emma Sangalang may publish in the future.

Co-authorship network of co-authors of Emma Sangalang

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Sangalang. A scholar is included among the top collaborators of Emma Sangalang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Sangalang. Emma Sangalang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 10
5 58
6 0
7 39
8 121
9 8
10 13

About Emma Sangalang

Emma Sangalang is a scholar working on Immunology, Ophthalmology and Oncology, having authored 10 papers that have together received 254 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Phagocytosis and Immune Regulation (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Immunology (211 citations), Oncology (76 citations) and Physiology (51 citations). Emma Sangalang has collaborated with scholars based in United States. Frequent co-authors include Amy Chen, Jaume Pons, Ons Harrabi, Hong Wan, Laura V. Doyle, Tracy C. Kuo, Steven E. Kauder, Bora Han, Sangeetha Bollini and Jonathan T. Sockolosky. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026